Few families are left untouched by the devastating problems caused by opioid misuse and addiction, which take the lives of about 50,000 people each year in the United States.
Gov. Ralph Northam on Thursday issued Executive Order Forty-Four, extending the Governor’s Advisory Commission on Opioids and Addiction for an additional year.
Attorney General Mark Herring has joined a coalition of 39 state attorneys general urging congressional leaders to remove federal barriers that prevent health care providers from offering opioid use disorder treatments.
Attorney General Mark Herring and his team have helped secure $1.4 billion from Reckitt Benckiser Group to resolve allegations of fraudulent marketing of the opioid treatment medication Suboxone.
A federal grand jury sitting in Abingdon has indicted Indivior Inc. and Indivior PLC (Indivior) for engaging in an illicit nationwide scheme to increase prescriptions of Suboxone Film.
The U.S. Department of Health and Human Services has released an additional $487 million to supplement first-year funding through its State Opioid Response (SOR) grant program.
Researchers from the Virginia Tech School of Neuroscience are teaming with the University of California San Diego and the U.S. National Institutes of Health to develop a drug – now in its earliest stages -– that can treat certain types of chronic pain without the addictive consequences of opioids.
VCU researchers are testing a vaccine against opioid abuse developed by the Scripps Research Institute in California. The vaccine is meant to block the effects of heroin and fentanyl in patients with opioid use disorder.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.